Loading
Statistician who ran the START, FAST-Forward and POETIC trials that reshaped breast cancer radiotherapy and endocrine therapy.
Judith Bliss directs the ICR Clinical Trials and Statistics Unit, which ran the UK START and FAST-Forward hypofractionation trials, IMPORT LOW and HIGH, POETIC and PERSEPHONE among many others, making it one of the most productive academic trial units in oncology. She has led methodological work on non-inferiority designs and long-term follow-up and is a senior author on most UK breast radiotherapy trials.
Shares IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer and the tags breast, radiotherapy.
Shares IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer and the tags breast, radiotherapy.
Shares IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer and the tags breast, radiotherapy.
Shares HR-positive / HER2-negative breast cancer and the tags biostatistics, breast.
Shares The Institute of Cancer Research, HR-positive / HER2-negative breast cancer and the tag breast.
Shares PERSEPHONE and the tag breast.
Shares The Institute of Cancer Research, HR-positive / HER2-negative breast cancer and the tag breast.
Shares The Institute of Cancer Research and the tag radiotherapy.